Cargando…

Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases

Identifying factors that influence problematic beliefs and behaviors related to pharmacotherapy may be useful for clinicians to improve the patients’ adherence. The study aims to assess patients’ beliefs about the necessity and concerns regarding pharmacotherapy in rheumatic diseases and attitude st...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosato, Sarah, Bonetto, Chiara, Zanini, Alice, Bixio, Riccardo, Marchel, Martina, Pacenza, Giulio, Galvagni, Isotta, Cristofalo, Doriana, Fracassi, Elena, Carletto, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803630/
https://www.ncbi.nlm.nih.gov/pubmed/36585438
http://dx.doi.org/10.1038/s41598-022-27046-5
_version_ 1784861927806074880
author Tosato, Sarah
Bonetto, Chiara
Zanini, Alice
Bixio, Riccardo
Marchel, Martina
Pacenza, Giulio
Galvagni, Isotta
Cristofalo, Doriana
Fracassi, Elena
Carletto, Antonio
author_facet Tosato, Sarah
Bonetto, Chiara
Zanini, Alice
Bixio, Riccardo
Marchel, Martina
Pacenza, Giulio
Galvagni, Isotta
Cristofalo, Doriana
Fracassi, Elena
Carletto, Antonio
author_sort Tosato, Sarah
collection PubMed
description Identifying factors that influence problematic beliefs and behaviors related to pharmacotherapy may be useful for clinicians to improve the patients’ adherence. The study aims to assess patients’ beliefs about the necessity and concerns regarding pharmacotherapy in rheumatic diseases and attitude styles, and to investigate the association between clinical factors and negative beliefs about medication. A sample of 712 patients affected by Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis was enrolled. They were assessed using the Beliefs about Medicines Questionnaires-Specific (BMQ), the Simplified Disease Activity Index (SDAI), the Visual Analogue Scale for pain (VAS), the Chalder Fatigue Scale (CFQ) and the Health Assessment Questionnaire-Disability Index (HAQ-DI). The balance between benefits and costs in the BMQ-Specific was positive in the 79.4% of patients, negative in the 12.1% and equal in the 8.6%. SDAI, taking more than 5 medications, taking anti interleukin 6 (Anti-IL6) or biological disease-modifying antirheumatic drugs (bDMARDs), or targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs), pain, and fatigue were significantly associated to higher Concerns. Having a longer disease duration was significantly associated with a higher Necessity, together with the current pharmacological treatments and the disability. The multivariate regression models estimated that higher pain and fatigue were associated to higher Concerns (p < 0.001), while a longer disease duration (p < 0.001) and all pharmacological treatments for a rheumatologic disease (p = 0.001) were associated to higher Necessity levels. A high length of disease, a low level of remission, a high number of total medications, the prescription of an Anti-IL6/bDMARDs/tsDMARDs drug, a high level of pain, fatigue and disability identified patients potentially less adherent to pharmacotherapy to be carefully looked after by clinicians.
format Online
Article
Text
id pubmed-9803630
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98036302023-01-01 Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases Tosato, Sarah Bonetto, Chiara Zanini, Alice Bixio, Riccardo Marchel, Martina Pacenza, Giulio Galvagni, Isotta Cristofalo, Doriana Fracassi, Elena Carletto, Antonio Sci Rep Article Identifying factors that influence problematic beliefs and behaviors related to pharmacotherapy may be useful for clinicians to improve the patients’ adherence. The study aims to assess patients’ beliefs about the necessity and concerns regarding pharmacotherapy in rheumatic diseases and attitude styles, and to investigate the association between clinical factors and negative beliefs about medication. A sample of 712 patients affected by Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis was enrolled. They were assessed using the Beliefs about Medicines Questionnaires-Specific (BMQ), the Simplified Disease Activity Index (SDAI), the Visual Analogue Scale for pain (VAS), the Chalder Fatigue Scale (CFQ) and the Health Assessment Questionnaire-Disability Index (HAQ-DI). The balance between benefits and costs in the BMQ-Specific was positive in the 79.4% of patients, negative in the 12.1% and equal in the 8.6%. SDAI, taking more than 5 medications, taking anti interleukin 6 (Anti-IL6) or biological disease-modifying antirheumatic drugs (bDMARDs), or targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs), pain, and fatigue were significantly associated to higher Concerns. Having a longer disease duration was significantly associated with a higher Necessity, together with the current pharmacological treatments and the disability. The multivariate regression models estimated that higher pain and fatigue were associated to higher Concerns (p < 0.001), while a longer disease duration (p < 0.001) and all pharmacological treatments for a rheumatologic disease (p = 0.001) were associated to higher Necessity levels. A high length of disease, a low level of remission, a high number of total medications, the prescription of an Anti-IL6/bDMARDs/tsDMARDs drug, a high level of pain, fatigue and disability identified patients potentially less adherent to pharmacotherapy to be carefully looked after by clinicians. Nature Publishing Group UK 2022-12-30 /pmc/articles/PMC9803630/ /pubmed/36585438 http://dx.doi.org/10.1038/s41598-022-27046-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Tosato, Sarah
Bonetto, Chiara
Zanini, Alice
Bixio, Riccardo
Marchel, Martina
Pacenza, Giulio
Galvagni, Isotta
Cristofalo, Doriana
Fracassi, Elena
Carletto, Antonio
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases
title Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases
title_full Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases
title_fullStr Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases
title_full_unstemmed Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases
title_short Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases
title_sort clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803630/
https://www.ncbi.nlm.nih.gov/pubmed/36585438
http://dx.doi.org/10.1038/s41598-022-27046-5
work_keys_str_mv AT tosatosarah clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT bonettochiara clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT zaninialice clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT bixioriccardo clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT marchelmartina clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT pacenzagiulio clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT galvagniisotta clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT cristofalodoriana clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT fracassielena clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases
AT carlettoantonio clinicalandpsychologicalcharacteristicsassociatedwithnegativebeliefsandconcernsabouttreatmentnecessityinrheumaticdiseases